Nafarelin acetate - Latest Advances

Trends in endometriosis interventions: an interrupted time series analysis following the Australian National Action Plan for Endometriosis (NAPE) 2018.

Journal: Australian health review : a publication of the Australian Hospital Association

Published: February 25, 2025

A study on the efficacy and safety of long-term adjusted low-dose gonadotropin-releasing hormone agonist therapy for uterine fibroids and adenomyosis.

Journal: The journal of obstetrics and gynaecology research

Published: March 09, 2024

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.

Journal: International journal of molecular sciences

Published: February 27, 2023

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

Journal: Human reproduction open

Published: November 12, 2022

GnRHa for trigger and luteal phase support in natural cycle frozen embryo transfer - A proof of concept study.

Journal: Reproductive biology

Published: April 29, 2020

Caspase-3 gene expression in human luteinized granulosa cells is inversely correlated with the number of oocytes retrieved after controlled ovarian stimulation.

Journal: Human fertility (Cambridge, England)

Published: July 26, 2017

Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.

Journal: Pharmaceutical development and technology

Published: April 22, 2017

INN Common stem: -relin.

Journal: Prescrire international

Published: January 01, 2017

Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.

Journal: Fertility and sterility

Published: February 24, 2016

p27 and its ubiquitin ligase Skp2 expression in endometrium of IVF patients with repeated hormonal stimulation.

Journal: Reproductive biomedicine online

Published: May 21, 2015

GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.

Journal: The Australian & New Zealand journal of obstetrics & gynaecology

Published: June 27, 2014

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.

Journal: Fertility and sterility

Published: June 20, 2013

Filters

Trends in endometriosis interventions: an interrupted time series analysis following the Australian National Action Plan for Endometriosis (NAPE) 2018.

Trends in endometriosis interventions: an interrupted time series analysis following the Australian National Action Plan for Endometriosis (NAPE) 2018.

A study on the efficacy and safety of long-term adjusted low-dose gonadotropin-releasing hormone agonist therapy for uterine fibroids and adenomyosis.

A study on the efficacy and safety of long-term adjusted low-dose gonadotropin-releasing hormone agonist therapy for uterine fibroids and adenomyosis.

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

GnRHa for trigger and luteal phase support in natural cycle frozen embryo transfer - A proof of concept study.

GnRHa for trigger and luteal phase support in natural cycle frozen embryo transfer - A proof of concept study.

Caspase-3 gene expression in human luteinized granulosa cells is inversely correlated with the number of oocytes retrieved after controlled ovarian stimulation.

Caspase-3 gene expression in human luteinized granulosa cells is inversely correlated with the number of oocytes retrieved after controlled ovarian stimulation.

Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.

Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.

INN Common stem: -relin.

INN Common stem: -relin.

Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.

Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.

p27 and its ubiquitin ligase Skp2 expression in endometrium of IVF patients with repeated hormonal stimulation.

p27 and its ubiquitin ligase Skp2 expression in endometrium of IVF patients with repeated hormonal stimulation.

GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.

GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.